Genome MedicineGenetic & Genomic MedicinePeer-reviewed journal article
Genotype-phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders
Ilaria MannucciiD, Nghi Doan-Phuong DangiD, Hannes HuberiD, Jaclyn B. MurryiD, Jeff AbramsoniD, Thorsten AlthoffiD, Siddharth BankaiD, Gareth S BaynamiD, David R. BeardeniD, Ana Beleza‐MeirelesiD, Paul J. Benke, Siren BerlandiD, Tatjana BierhalsiD, Frédéric BilaniD, Laurence Albert BindoffiD, Geir J. BraatheniD, Øyvind L. BuskiD, Jirat ChenbhanichiD, Jonas DeneckeiD, Luis EscobariD, Caroline Estes, Julie A. FleischeriD, Daniel GroepperiD, Charlotte A. HaaxmaiD, Maja HempeliD, , Davor LesseliD
Abstract
BackgroundWe aimed to define the clinical and mutational spectrum, and to provide novel molecular insights into DHX30-associated neurodevelopmental disorder. MethodsClinical and genetic data from affected individuals were collected through family support group, GeneMatcher and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30-deficient HEK293T and zebrafish models, along with in vivo behavioral assays. ResultsWe identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual bearing a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location and type we establish two distinct clinical subtypes. DHX30 loss-of-function mutations cause a milder phenotype whereas a severe phenotype is caused by HCM missense mutations that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of function with respect to SG formation. Behavioral characterization of dhx30 deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype. ConclusionsOur study highlights the usefulness of social media in order to define novel Mendelian disorders, and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories and research laboratories.
- organism: zebrafish
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
- Citations
- 35
- FWCI
- 3.39
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathogenic DDX3X mutations impair RNA metabolism and neurogenesis during fetal cortical development
Ashley L. Lennox, Mariah L. Hoye, … Elliott H. Sherr·NeuronPeer-reviewed·Mar 4, 2020
- Monoallelic variation in DHX9, the gene encoding the DExH-box helicase DHX9, underlies neurodevelopment disorders and Charcot-Marie-Tooth disease
Daniel G. Calame, Tianyu Guo, … James R. Lupski·medRxiv·Mar 1, 2023
- Distinct disease mutations in DNMT3A result in a spectrum of behavioral, epigenetic, and transcriptional deficits
Diana C. Beard, Xiyun Zhang, … Harrison W. Gabel·Cell ReportsPeer-reviewed·Nov 1, 2023
- De novo and inherited variants in DDX39B cause a Novel Syndrome Characterized by Neurodevelopmental Delay, Short Stature, and Congenital Hypotonia
Kevin T. A. Booth, Sharayu V. Jangam, … Francesco Vetrini·medRxiv·Jul 15, 2023
- De novo HDAC3 variants leading to epigenetic machinery dysfunction are associated with a neurodevelopmental disorder
Jihoon G. Yoon, Seong-Kyun Lim, … Chul‐Hwan Lee·medRxiv·Jan 29, 2024
- A novel neurodevelopmental syndrome caused by loss-of-function of the Zinc Finger Homeobox 3 (ZFHX3) gene
María del Rocío Pérez Baca, Eva Jacobs, … Dorothea Wand·The American Journal of Human GeneticsPeer-reviewed·Feb 26, 2024